IP Library Granted Patent US 7,192,614
Granted Patent B2
US 7,192,614 · App. 10/457,033 · Granted Mar 20, 2007

Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms

Assignee: GelStat Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,192,614
App. No.
10/457,033
Granted
Mar 20, 2007
Kind
B2
Abstract

Methods of treating migrainous headaches and their associated symptoms are provided by administering a composition comprising parthenolide or feverfew sublingually to a patient in need thereof. Treatments are surprisingly effective with low total administered amounts of parthenolide or feverfew. Compositions and unit dose systems are also described.

Claims (12)

1. A method of treating migrainous headaches, comprising administering an aqueous composition consisting essentially of feverfew extract and ginger extract sublingually to a patient in need thereof in a total administered amount of from about 4 mg to about 40 mg of feverfew extract in a two hour period.

2. The method of claim 1 , wherein said total administered amount is from about 4 mg to about 20 mg of feverfew extract in a two hour period.

3. The method of claim 1 , wherein said the feverfew extract has a standardized parthenolide concentration of from about 1.2% to about 10%.

4. The method of claim 1 , wherein said composition additionally comprises a mucosal permeation enhancer.

5. The method of claim 1 , wherein said composition has a pH of from about 2 to about 6.

6. The method of claim 1 , wherein said composition has a pH of from about 3.0 to about 6.0.

7. The method of claim 1 , wherein said composition further comprises 0.05–5% ascorbic acid and 0.05–5% sodium lauryl sulfate.

8. The method of claim 7 , wherein said total administered amount is divided among a plurality of compositions, and said plurality of compositions are administered sequentially.

9. The method of claim 1 , wherein said composition is held sublingually for at least about 30 seconds prior to swallowing.

10. The method of claim 1 , wherein said composition is circulated about the mouth prior to swallowing.

11. A method of treating migrainous headaches, comprising administering an aqueous composition consisting essentially of feverfew extract and ginger extract sublingually to a patient in need thereof in a total administered amount of from about 4 mg to about 40 mg of feverfew extract in a 24 hour period.

12. The method of claim 11 , wherein the feverfew extract is administered in at least two doses, and wherein each individual dose of feverfew extract does not exceed about 10 mg.

Assignments (16)
SECURITY INTEREST Recorded May 28, 2021
From: PER OS BIOSCIENCES, LLC
To: BRISBEN, WILLIAM O.
Reel/Frame 056384/0672 →
SECURITY INTEREST Recorded Oct 23, 2018
From: PER OS BIOSCIENCES, LLC
To: BRISBEN, WILLIAM O.
Reel/Frame 047288/0427 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2018
From: MASTIX, LLC
To: PER OS BIOSCIENCES, LLC
Reel/Frame 047288/0446 →
SECURITY INTEREST Recorded Jul 19, 2016
From: MASTIX, LLC
To: BRISBEN, WILLIAM O.
Reel/Frame 039182/0879 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2016
From: GELSTAT CORPORATION
To: MASTIX, LLC
Reel/Frame 039168/0182 →
SECURITY AGREEMENT Recorded Nov 18, 2015
From: MASTIX MEDICA, LLC; GELSTAT CORPORATION
To: BRISBEN PROPERTIES LLC
Reel/Frame 037129/0425 →
SHARE EXCHANGE AGREEMENT Recorded May 8, 2012
From: GSC DIRECT, INC.
To: GELSTAT CORPORATION
Reel/Frame 028171/0410 →
CHANGE OF NAME Recorded Apr 22, 2011
From: HIGH ALPHA PARTNERS, INC.
To: GSC DIRECT, INC.
Reel/Frame 026170/0115 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2010
From: KLOS, STEVEN, DR.
To: HIGH ALPHA PARTNERS, INC. D/B/A/ GELSTAT DIRECT
Reel/Frame 023915/0799 →
COURT ORDER (SEE ATTACHED) Recorded Apr 21, 2009
From: GELSTAT CORPORATION, BY ITS COURT APPOINTED RECEIVER, MARK D. LUTHER
To: KLOS, STEVEN, C/O MARK LUTHER HIS ATTORNEY MARK LUTHER LAW OFFICE
Reel/Frame 022610/0640 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2008
From: G3PRA, LLC; GELSTAT CORPROATION
To: G3PRA, LLC
Reel/Frame 021658/0673 →
STIPULATION OF SETTLEMENT AND ORDER Recorded Sep 9, 2008
From: KLOS, DR. STEVEN
To: GELSTAT CORPORATION
Reel/Frame 021518/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2008
From: KLOS, STEVEN, DR.
To: GELSTAT CORPORATION
Reel/Frame 021450/0198 →
SHERIFFS SALE Recorded Jul 25, 2008
From: GELSTAT CORPORATION
To: DR. STEVEN KLOS
Reel/Frame 021302/0228 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2008
From: GELSTAT CORPORATION
To: DR. STEVEN KLOS
Reel/Frame 021302/0129 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2007
From: MITCHELL, RUSSELL W.; HIGGINS, JAMES W.; ROBERTS, STEPHEN C.
To: GELSTAT CORPORATION
Reel/Frame 018871/0113 →
Continuity (2)
Continuation In Part 1028861000 · Nov 5, 2002
Related Publication 20040086582A1 · May 6, 2004